NS Wind Down Co., Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $127.3M | $145.1M | $117.3M | $125.6M | $106.7M | $114.9M |
| Operating income | −$152.2M | −$108.2M | −$88.0M | −$82.7M | −$69.4M | −$38.2M |
| Net income | −$159.5M | −$115.3M | −$110.1M | −$40.7M | −$77.4M | −$43.6M |
| Total assets | $353.4M | $479.5M | $544.2M | $259.8M | $147.6M | $136.8M |
| Total liabilities | $307.6M | $302.5M | $237.2M | $155.6M | $110.7M | $96.7M |
| Equity | $45.8M | $177.0M | $306.9M | $104.2M | $36.9M | $40.1M |
| EPS (diluted) | $-3.44 | $-2.54 | $-2.82 | $-0.69 | — | — |
| Shares out. | 45.9M | 44.6M | 37.0M | 31.1M | 25.4M | 21.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −119.6%
- Net margin
- −125.4%
- Return on equity
- −348.2%
- Return on assets
- −45.1%
- Return on capital (ROCE)
- −51.7%
- Liabilities / assets
- 87.0%
- Debt / equity
- 6.71×
- Book value / share
- $1.00
- Revenue growth (YoY)
- −12.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -5.97distress
- Accruals / assets
- −8.8%clean
- Beneish M-Score
- -3.14normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 10, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 15, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Beechem Joseph MOfficer — SVP, Research & Development | May 6, 2024 | Option exercise | 8,460 | $0.00 |
| Bailey K ThomasOfficer — Chief Financial Officer | May 6, 2024 | Option exercise | 8,460 | $0.00 |
| George JanetDirector | May 6, 2024 | Option exercise | 41,133 | $0.00 |
| Rollison Dana E.Director | May 6, 2024 | Option exercise | 41,133 | $0.00 |
| Foy Teresa M.Director | May 6, 2024 | Option exercise | 3,842 | $0.00 |
| Norden GregoryDirector | May 6, 2024 | Option exercise | 41,133 | $0.00 |
| Garland Jonathan ToddOfficer — Chief Commercial Officer | May 6, 2024 | Option exercise | 200,000 | $0.00 |
| Waite Charles P JrDirector | May 6, 2024 | Option exercise | 41,133 | $0.00 |
| Gray R BradleyOfficer — President and CEO | May 6, 2024 | Option exercise | 26,321 | $0.00 |
| Malloy KirkDirector | May 6, 2024 | Option exercise | 41,133 | $0.00 |
| Young WilliamDirector | May 6, 2024 | Option exercise | 41,133 | $0.00 |
| Finney Elisha WDirector | May 6, 2024 | Option exercise | 41,133 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Modified shareholder rights · Change in control · Director / officer change · Other material eventJun 26, 2024
- Modified shareholder rightsJun 20, 2024
- Modified shareholder rights · Amended charter or bylawsMay 28, 2024
- Regulation FD disclosureMay 22, 2024
- Modified shareholder rightsMay 8, 2024
- Completed an acquisition or disposition · Director / officer change · Other material eventMay 6, 2024
- Regulation FD disclosureApr 22, 2024
- Entered a material agreement · Terminated a material agreement · Other material eventApr 19, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.